Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00139
|
|||||
| EM Name |
Eicosapentaenoic acid
|
|||||
| Synonyms |
Eicosapentaenoic acid; Timnodonic acid; Icosapent; Icosapentaenoic acid; EPA; 5,8,11,14,17-EICOSAPENTAENOIC ACID; Icosapentum; Icosapento; 5Z,8Z,11Z,14Z,17Z-Eicosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid; cis-5,8,11,14,17-Eicosapentaenoic acid; UNII-AAN7QOV9EA; (all-Z)-5,8,11,14,17-Eicosapentaenoic acid; Icosapent [INN]; CCRIS 3279; (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid; AAN7QOV9EA; C20:5 omega-3; 5,8,11,14,17-Icosapentaenoic acid; CHEMBL460026
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=446284"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H30O2
|
|||||
| Canonical SMILES |
CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O
|
|||||
| InChI |
InChI=1S/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15-
|
|||||
| InChIKey |
JAZBEHYOTPTENJ-JLNKQSITSA-N
|
|||||
| CAS Number |
CAS 10417-94-4
|
|||||
| Pharmaceutical Properties | Molecular Weight | 302.5 | Topological Polar Surface Area | 37.3 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 13 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:28364
|
|||||
| DT(s) "handling" This EM | ABCD1 | Transporter Info | Adrenoleukodystrophy protein | [1] | ||
| References | ||||||
| 1 | Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy. Hum Mol Genet. 2015 Dec 15;24(24):6861-76. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.